FDA Approves Vyvgart™ (efgartigimod) for Adults with Generalized Myasthenia GravisOn December 17, 2021, the U.S. Food and Drug Administration (FDA) approved Vyvgart™ (efgartigimod) to treat generalized myasthenia gravis (gMG) in adults who test positive for the anti-acetylcholine receptor (AChR)... By Editorial Team2 min readBookmark for laterReactions 0 reactions Comments0 comments
What to Know About Philips CPAP and Ventilator RecallAfter many months of investigation, Philips has announced a recall notification for many of its devices. The medical device company analyzed risks related to several products, including:1,2 In the United... By Editorial Team2 min readBookmark for laterReactions 0 reactions Comments0 comments
